Programme
Are you presenting
at ILCA Annual Conference?
Check the guidelines and you need to
submit for your presentation
Join the global liver cancer community for ILCA’s 20 Anniversary and be part of the conference by showcasing your latest scientific discoveries and helping shape the future of the field.
ILCA Annual Conference
Message from the Programme Committee Chair
This year’s programme brings together the most clinically and scientifically relevant topics in primary liver cancer, covering everything from basic and translational research to evidence‑based management of hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA). Our line‑up of speakers will share the latest advances in surveillance, diagnostics, treatment strategies, and survivorship across the entire disease spectrum.
You can expect an international, multidisciplinary faculty who will not only deliver comprehensive presentations but also lead meaningful discussions aimed at deepening scientific understanding, improving clinical practice, and highlighting unmet needs in the field. Sessions will be highly interactive and designed to encourage open, thoughtful dialogue on current controversies, methodological challenges, and future research directions in liver cancer
Amit Singal
ILCA Annual Conference 2026, Programme Committee Chair
Programme Overview
Explore the sessions at #ILCA26
Meet the Speakers
Meet #ILCA26 Programme Committee
Amit Singal
[University of Texas Southwestern Medical Center, USA]
Jesper Andersen
[University of Copenhagen, Denmark]
Julius Chapiro
[Yale University School of Medicine, USA]
Valerie Chew
[A*STAR Singapore; Translational Immunology Institute (TII); Duke-NUS Medical School, Singapore]
Hong Jae Chon
[CHA Bundang Medical Center, CHA University, South Korea]
Tim Greten
[National Cancer Institute (USA), National Institutes of Health, USA]
Ashish Kumar
[Sir Ganga Ram Hospital, India]
Anja Lachenmayer
[University Hospital Bern, Bern, Switzerland]
Robert J Lewandowski
[Northwestern University; Robert H. Lurie Comprehensive Cancer Center, USA]
Josep M Llovet
[Icahn School of Medicine at Mount Sinai; IDIBAPS–Hospital Clínic; University of Barcelona, Spain]
Grainne O’Kane
[St. Vincents' University Hospital and University College Dublin, Ireland]
Federico Piñero
[Hospital Universitario Austral, Austral University, Argentina]
Pil Soo Sung
[The Catholic University of Korea, Seoul St. Mary's Hospital, South Korea]
Bachir Taouli
[Icahn School of Medicine at Mount Sinai, USA]
Nguyen H Tran
[Mayo Clinic, Rochester MN, USA]
Georgios Tsoulfas
[Aristotle University of Thessaloniki School of Medicine, Greece]
Carmen Wong
[University of Hong Kong (HKU), Hong Kong]
Qinghe Zeng
[University Hospital Heidelberg, Germany]